PMID 28108470
Researchers at the University of Texas Medical Branch first characterized 5-amino-1mq in 2017 while searching for ways to inhibit NNMT, an enzyme they had identified as a key regulator of fat cell metabolism
The peptide, derived from the C-terminal fragment of human growth hormone (amino acids 176-191), targets adipose tissue specifically without the broader metabolic effects associated with full growth hormone therapy

COA Analysis & Summary 5-Amino 1MQ CAS: 42088-70-8 Formula: C 11 H 14 N 2 O Molecular Weight: 190.24 g/mol 5-Amino 1MQ 5 mg Cap/Crimp: Clear / Green Avg Mass: 5.80 mg | Avg Purity: 99.72% | Tests: 2 Current Batch A25AM0925 Janoshik + Freedom Diagnostics (2 tests, 2 vials) Avg Mass 5.80 mg Per test: 4.98 / 6.62 mg Avg Purity 99.72% Range: 99.722% Overfill vs 5 mg +16.00% Avg across 2 tests Test Results Current Batch Summary 5-Amino 1MQ 10 mg Cap/Crimp: Orange / Silver Avg Mass: 9.94 mg | Avg Purity: 99.76% | Tests: 2 Current Batch A25AM101125 Janoshik + Freedom Diagnostics (2 tests, 2 vials) Avg Mass 9.94 mg Per test: 10.27 / 9.61 mg Avg Purity 99.76% Range: 99.796% Overfill vs 10 mg -0.60% Avg across 2 tests Test Results Current Batch Summary For Research Use Only Not for Human or Veterinary Consumption
References Dimet-Wiley, A., Wu, Q., Wiley, J., Eswar, A., Neelakantan, H., Savidge, T., & Watowich, S
Our Opening Hours Monday Friday: 8am - 6pm Saturday: 8am - 1pm Closed Sunday & Public Holidays